Gemcitabine-induced pulmonary toxicity

Anticancer Research

Volumn 32, Issue 9, 2012, Pages 4147-4149

  Chi, Dow Chung ^a   Brogan, Frances ^a   Turenne, Ithamar ^a   Zelonis, Sarah ^a   Schwartz, Lawrence ^a   Saif, Muhammad Wasif ^a  

^a TUFTS MEDICAL CENTER   (United States)

Author keywords

Bronchiolitis obliterans organizing pneumonia; Gemcitabine; Pancreatic neoplasms; Pneumonia

Indexed keywords

AZITHROMYCIN; BIOLOGICAL MARKER; CONTRAST MEDIUM; CORTICOSTEROID; COTRIMOXAZOLE; GEMCITABINE; OSELTAMIVIR; OXYGEN; PIPERACILLIN PLUS TAZOBACTAM; TOBRAMYCIN; VANCOMYCIN;

ADJUVANT CHEMOTHERAPY; ADULT; ARTICLE; CANCER STAGING; CANCER SURGERY; CASE REPORT; CHEST TIGHTNESS; COMPUTED TOMOGRAPHIC ANGIOGRAPHY; CONTRAST ENHANCEMENT; DISEASE COURSE; DRUG MEGADOSE; DYSPNEA; ELECTROCARDIOGRAM; EMPHYSEMA; EXERCISE TOLERANCE; FOLLOW UP; FUNCTIONAL STATUS; HEART INFARCTION; HEART PALPITATION; HOSPITAL DISCHARGE; HOSPITALIZATION; HUMAN; HUMAN TISSUE; LUNG TOXICITY; MALE; MULTIPLE CYCLE TREATMENT; NUCLEAR MAGNETIC RESONANCE IMAGING; OXYGEN SATURATION; OXYGEN THERAPY; PANCREAS CANCER; PANCREATICODUODENECTOMY; PNEUMONIA; PRESCRIPTION; PRIORITY JOURNAL; TRANSBRONCHIAL BIOPSY; TREATMENT RESPONSE;

ANTIMETABOLITES, ANTINEOPLASTIC; DEOXYCYTIDINE; HUMANS; MALE; MIDDLE AGED; PANCREATIC NEOPLASMS; PNEUMONIA;

EID: 84867003427     PISSN: 02507005     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (5)

1. Di Marco M, Di Cicilia R, Macchini M, Nobili E, Vecchiarelli S, Brandi G and Biasco G: Metastatic pancreatic cancer: Is gemcitabine still the best standard treatment? Oncol Rep 23: 1183-1192, 2010.
2. Burris HA, Moore MJ, Andersen J, Green MR, Rothenberg ML, Modiano MR, Cripps MC, Portenoy RK, Storniolo AM, Tarassoff P, Nelson R, Dorr FA, Stephens CD and Von Hoff DD: Improvements in survival and clinical benefit with gemcitabine as first-line therapy for patients with advanced pancreas cancer: A randomized trial. J Clin Oncol 15: 2403-2413, 1997.
3. Louvet C, Labianca R, Hammel P, Lledo G, Zampino MG, André T, Zaniboni A, Ducreux M, Aitini E, Taïeb J, Faroux R, Lepere C and de Gramont A: Gemcitabine in combination with oxaliplatin compared with gemcitabine alone in locally advanced or metastatic pancreatic cancer: Results of a GERCOR and GISCAD phase III trial. J Clin Oncol 23: 3509-3516, 2005.
4. Saif MW: Pulmonary toxicity associated with gemcitabine. J Pancreas 11(2): 189-190, 2010.
5. Shaib W, Lansigan F, Cornfeld D, Syrigos K and Saif MW: Gemcitabine-induced pulmonary toxicity during adjuvant therapy in a patient with pancreatic cancer. J Pancreas 9(6): 708-714, 2008.